Christopher Defilippi
Cardiovascular Disease · Baltimore, MDNPI 1639127301
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $70,198 of the $100,682 with a category attached, or 69.7%. 15 manufacturers reported payments, led by Siemens Medical Solutions USA, Inc. at 28.4% of the total. Reporting peaked in 2023 at $28,143 and has fallen 60.5% since, to $11,113 in 2025. Among cardiovascular disease clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 76 payments — averaging $1324.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Siemens Medical Solutions USA, Inc.$29K
- Ortho-clinical Diagnostics, Inc.$21K
- Abbott$18K
- Fujirebio Diagnostics, Incorporated$9K
- Roche Diagnostics Corporation$8K
- Roche Diagnostics International Ltd$6K
- plus $10K from 9 others
Across 352 payments — averaging $25,869 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$2.6M
- Abbott$2.5M
- Ortho-clinical Diagnostics, Inc.$1.3M
- Roche Diagnostics Corporation$1.1M
- Roche Molecular Systems, Inc.$638K
- Siemens Medical Solutions USA, Inc.$606K
- plus $399K from 5 others
What the payments were for
- Consulting fees$70,19870%
- Speaking & faculty fees$26,79327%
- Travel & lodging$1,5152%
- Food & beverage$2,1762%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 16 | $28,638 |
| Ortho-clinical Diagnostics, Inc. | 11 | $20,948 |
| Abbott | 13 | $17,919 |
| Fujirebio Diagnostics, Incorporated | 2 | $9,060 |
| Roche Diagnostics Corporation | 9 | $7,868 |
| Roche Diagnostics International Ltd | 2 | $6,033 |
| Polymedco, LLC | 3 | $5,300 |
| Quidel Corporation | 4 | $3,650 |
| Lumiradx, Inc. | 1 | $300 |
| Philips North America LLC | 2 | $300 |
| Amgen | 8 | $294 |
| AstraZeneca | 2 | $199 |
| Kestra Medical Technology Services, Inc. | 1 | $100 |
| Novo Nordisk | 1 | $57 |
| CSL Behring | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CD cobas Reagents$7,680
- Alinity$6,600
- VITROS 3600 IMMUNODIAGNOSTIC SYSTEM$3,750
- XIENCE SIERRA$3,635
- In-vitro diagnostic reagents$3,300
- OPTIS$2,400
- cobas 6800 System$2,308
- ALERE CHOLESTECH LDX$2,100
- Afinion 2$1,800
- Architect$1,200
- ADVIA Centaur XP Analyzer$200
- (3126) ECC Solutions$150
- (5044) MCOT$150
- Assure WCD$100
How this compares
$100,682 in reported general payments places this provider in the 95th percentile of 507 cardiovascular disease providers in Maryland.
Other cardiovascular disease in Baltimore
- Navin KapurBaltimore$1.5M
- Michael BlahaBaltimore$609K
- Sanjay RajagopalanBaltimore$521K
- Erin MichosBaltimore$257K
- Seth MartinBaltimore$166K
- Erika FellerBaltimore$121K
- Charles CummingsBaltimore$114K
- John RickardBaltimore$109K
- David KassBaltimore$90K
- Hiroshi AshikagaBaltimore$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.